These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 6187129

  • 1. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ, Brandriss MW, Monath TP.
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [Abstract] [Full Text] [Related]

  • 2. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA, Buckley A, Cammack N, Barrett AD, Clegg JC, Ishak R, Varma MG.
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [Abstract] [Full Text] [Related]

  • 3. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).
    Lobigs M, Dalgarno L, Schlesinger JJ, Weir RC.
    Virology; 1987 Dec; 161(2):474-8. PubMed ID: 2446422
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD, Monath TP, Cropp CB, Adkins JA, Ledger TN, Gould EA, Schlesinger JJ, Kinney RM, Trent DW.
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [Abstract] [Full Text] [Related]

  • 5. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA, Buckley A, Cane PA, Higgs S, Cammack N.
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [Abstract] [Full Text] [Related]

  • 6. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
    Schlesinger JJ, Brandriss MW, Walsh EE.
    J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
    [Abstract] [Full Text] [Related]

  • 7. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD, Mathews JH, Miller BR, Medlen AR, Ledger TN, Roehrig JT.
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
    Brandriss MW, Schlesinger JJ, Walsh EE.
    J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
    [Abstract] [Full Text] [Related]

  • 9. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
    Buckley A, Gould EA.
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
    [Abstract] [Full Text] [Related]

  • 10. Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus.
    Cammack N, Gould EA.
    Virology; 1986 Apr 30; 150(2):333-41. PubMed ID: 2421479
    [Abstract] [Full Text] [Related]

  • 11. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.
    Monath TP, Schlesinger JJ, Brandriss MW, Cropp CB, Prange WC.
    Am J Trop Med Hyg; 1984 Jul 30; 33(4):695-8. PubMed ID: 6206738
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
    Davis EH, Beck AS, Strother AE, Thompson JK, Widen SG, Higgs S, Wood TG, Barrett ADT.
    mBio; 2019 Oct 22; 10(5):. PubMed ID: 31641088
    [Abstract] [Full Text] [Related]

  • 14. Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine.
    Mason RA, Tauraso NM, Spertzel RO, Ginn RK.
    Appl Microbiol; 1973 Apr 22; 25(4):539-44. PubMed ID: 4633476
    [Abstract] [Full Text] [Related]

  • 15. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ, Chapman S.
    J Gen Virol; 1995 Jan 22; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW, Schlesinger JJ, Walsh EE, Briselli M.
    J Gen Virol; 1986 Feb 22; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [Abstract] [Full Text] [Related]

  • 18. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas.
    Monath TP, Craven RB, Muth DJ, Trautt CJ, Calisher CH, Fitzgerald SA.
    Am J Trop Med Hyg; 1980 Jul 22; 29(4):624-34. PubMed ID: 7406113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.